BOT:ASX
Botanix Pharmaceuticals Ltd
A$0.0090
0.00%
(0.00) 1D
Nov 5, 12:42:33 PM GMT+11 · AUD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for BOT...
Open
A$0.01
High
A$0.01
Low
A$0.01
Mkt. cap
24.86M
Avg. vol.
9.08M
Volume
1.94M
52-wk high
A$0.15
52-wk low
A$0.01
EPS
-A$0.03
Shares outstanding
2.76B
No. of employees
11
Open
A$0.01
High
A$0.01
Low
A$0.01
Mkt. cap
24.86M
Avg. vol.
9.08M
Volume
1.94M
52-wk high
A$0.15
52-wk low
A$0.01
EPS
-A$0.03
Shares outstanding
2.76B
No. of employees
11
News stories
From web sources and news partners
KITV
·
1 hour ago
Dow has best post-midterm elections day in 44 years as Democrats take control of Congress
ChartMill
·
4 hours ago
S&P 500 After-Hours Losers: FICO, EXPE, QCOM Lead Postmarket Declines
Traders Union
·
3 hours ago
Michael Kantro: Correlation between cap and equal-weighted S&P 500 falls to 37%
Profile
Botanix Pharmaceuticals is listed on the Australian Securities Exchange with the issue code BOT. The Company is headquartered in Perth, Western Australia and Philadelphia, USA. It is a clinical stage synthetic cannabinoid company, focusing on the compound Cannabidiol. The company's lead product is Sofdra, which treats axillary hyperhidrosis. The company has two separate development platforms, dermatology and antimicrobial. Botanix also has an exclusive license to use a proprietary drug delivery system Permetrex, for direct skin delivery of active pharmaceuticals which is utilised in all of their programs. Wikipedia
About Botanix Pharmaceuticals Ltd
CEO-
Employees11
Founded1984
Headquarters-
SectorPharmaceutical industry
Industry-
Websitebotanixpharma.com